Research Paper Volume 13, Issue 9 pp 12865—12895

Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma

Validation of the diagnostic efficiency for each of the 10 hub genes. (A–F) Performance of the 10 hub genes in discriminating HCV-HCC from normal control based on GSE69715 (A, B), GSE107170 (C, D), and TCGA-LIHC (E, F). (G, H) Potential utilities of the hub genes for early tumor detection based on ICGC-LIRI-JP. HCV-HCC, HCV- associated HCC.

Figure 7. Validation of the diagnostic efficiency for each of the 10 hub genes. (AF) Performance of the 10 hub genes in discriminating HCV-HCC from normal control based on GSE69715 (A, B), GSE107170 (C, D), and TCGA-LIHC (E, F). (G, H) Potential utilities of the hub genes for early tumor detection based on ICGC-LIRI-JP. HCV-HCC, HCV- associated HCC.